Registry of Lobbyists
Total Number of Communication Reports: 2
Monthly communication reports in the last 6 months: 0
Version 1 of 12 (1996-03-11 to 2005-06-10) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Consultant lobbyist name: | LESTER SCHEININGER Lobbyist business address |
| Consulting firm: |
BRESVER, GROSSMAN, SCHEININGER & DAVIS
2800 - 390 BAY STREET TORONTO, ON M5H 2Y2 Canada |
| Position: | PARTNER |
| Telephone number: | 416-869-0366 |
| Fax number: | 416-869-0321 |
| Former public office holder: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Payment is contingent on the success of the undertaking: | No |
| Client: |
APOTEX INC.
150 SIGNET DRIVE WESTON, ON M9L 1T9 Canada |
| Telephone number: | 416-749-9300 Ext.: 0 |
| Fax number: | 416-749-9578 |
| Client Representative: |
JACK
RAY
|
| Parent: | The client is not a subsidiary of any other parent companies. |
| Coalition: | The client is not a coalition. |
| Subsidiary: | The client does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Individual, organization or corporation: | The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada | ||||||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||||||
| Subject Matter: Areas of Concern: | Health, Intellectual Property | ||||||||||
Details Regarding the Identified Subject Matter
|
|||||||||||